Sign in
4/A

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-13-052149

Options or other derivatives

  • Director acquired 530,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Waksal Harlan · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2013-09-13 Grant or award : show line 1 in the form Common Stock Option +530,000 $0.05 2023-09-13 530,000 3,236,572 D
Loading xslF345X03/form4a62353_20130924034752-.xml…